Structure Therapeutics (GPCR) Interest & Investment Income (2022 - 2026)

Structure Therapeutics' Interest & Investment Income history runs 5 years deep, the most recent figure standing at $13.6 million for Q1 2026.

• In Q1 2026, Interest & Investment Income rose 42.03% year-over-year to $13.6 million; the TTM figure through Mar 2026 stood at $39.9 million (up 0.8% YoY), while the FY2025 annual figure was $35.9 million, changed 0.39% from the prior year.
• Interest & Investment Income was $13.6 million for Q1 2026 at Structure Therapeutics, up from $9.2 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $13.6 million in Q1 2026 to a low of -$69000.0 in Q1 2022.
• Historically, Interest & Investment Income has averaged $5.9 million across 5 years, with a median of $6.2 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Interest & Investment Income jumped 3617.11% in 2023, then sank 31.53% in 2025.
• A 5-year view of Interest & Investment Income shows it stood at $901000.0 in 2022, then jumped by 585.79% to $6.2 million in 2023, then surged by 73.46% to $10.7 million in 2024, then dropped by 14.3% to $9.2 million in 2025, then soared by 48.08% to $13.6 million in 2026.
• The last three Interest & Investment Income figures came in at $13.6 million (Q1 2026), $9.2 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.